- $381.92m
- $340.48m
- $6.03m
- 46
- 52
- 62
- 53
Annual income statement for Anterix, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.921 | 1.08 | 1.92 | 4.19 | 6.03 |
| Cost of Revenue | |||||
| Gross Profit | 0.515 | 1.08 | 1.92 | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 55.7 | 37.9 | 18.4 | 14.3 | 17.7 |
| Operating Profit | -54.8 | -36.8 | -16.5 | -10.1 | -11.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -54.3 | -36.5 | -15.1 | -7.51 | -9.48 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -54.4 | -37.5 | -16.3 | -9.13 | -11.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -54.4 | -37.5 | -16.3 | -9.13 | -11.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -54.4 | -37.5 | -16.3 | -9.13 | -11.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.97 | -2.47 | -2.19 | -1.95 | -1.92 |